Reply to thread

That would be a good assumption based on the history of pharmaceutical acquisitions. However, I worked directly for AZ and was displaced a few years back so they could add a contract rep to sell nexium. Their belief is the CSO reps cost less and are equally effective.so it could potentially go either way. Only time will tell